HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.

AbstractGOALS:
To evaluate the impact of age on the prognosis of patients with hepatocellular carcinoma (HCC) undergoing percutaneous radiofrequency ablation (RFA).
BACKGROUND:
Whether age plays an important role in the outcomes of HCC after RFA remains controversial.
STUDY:
Two hundred fifty-eight consecutive treatment naive HCC patients who underwent RFA were enrolled. Patients aged ≤ 65 years (n = 100) were defined as the younger group and those aged > 65 years (n = 158) were the elderly group. Their clinicopathologic features and prognosis were compared.
RESULTS:
Younger patients had a higher male-to-female ratio, higher prevalence of hepatitis B virus, and smaller tumor size than elder patients. After median follow-up of 28.5 ± 18.7 months, 45 patients died. The cumulative 5-year survival rates were 81.3% and 65.4% in younger and elder HCC patients, respectively (P = 0.008). Multivariate analysis disclosed that age > 65 years, serum albumin level ≤ 3.7 g/dL, prothrombin time international normalized ratio > 1.1, α-fetoprotein (AFP) > 20 ng/mL, and no antiviral therapy after RFA were independent risk factors associated with poor overall survival. Besides, there were 163 patients with tumor recurrence after RFA. Multivariate analysis showed that age > 65 years, platelet count ≤ 10/mm, AFP > 20 ng/mL, multinodularity, and tumor size > 2 cm were the independent risk factors predicting recurrence.
CONCLUSIONS:
Both liver functional reserve (serum albumin level, prothrombin time international normalized ratio, platelet count, and antiviral therapy) and tumor factors (tumor size, number, and AFP level) were crucial in determining post-RFA prognosis in HCC patients. Moreover, younger HCC patients have better overall survival and lower recurrence rate after RFA compared with elder patients.
AuthorsWei-Yu Kao, Yi-You Chiou, Hung-Hsu Hung, Chien-Wei Su, Yi-Hong Chou, Teh-Ia Huo, Yi-Hsiang Huang, Wen-Chieh Wu, Han-Chieh Lin, Shou-Dong Lee, Jaw-Ching Wu
JournalJournal of clinical gastroenterology (J Clin Gastroenterol) Vol. 46 Issue 1 Pg. 62-70 (Jan 2012) ISSN: 1539-2031 [Electronic] United States
PMID21934530 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Carcinoma, Hepatocellular (pathology, surgery)
  • Catheter Ablation (methods)
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Liver Neoplasms (pathology, surgery)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Recurrence, Local
  • Prevalence
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Sex Factors
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: